TITLE

Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus

AUTHOR(S)
Rasul, Sazan; Wagner, Ludwig; Kautzky-Willer, Alexandra
PUB. DATE
December 2012
SOURCE
Endocrine (1355008X);Dec2012, Vol. 42 Issue 3, p496
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Although type 2 diabetes mellitus (DM) is a chronic metabolic disorder with multiple etiologies, obesity has been constantly linked with insulin resistance and manifestation of type 2 DM. In addition, obesity is associated with hypertension, dyslipidemia, and fatty liver disease and is regarded as a subclinical inflammatory condition characterized by release of pro-inflammatory mediators such as cytokines from adipose tissue. Both, type 2 DM and obesity are considered as major risks for developing micro- and macrovascular diseases. Recent studies showed that impaired circulating levels of fetuin-A, which is involved in propagating insulin resistance as well as circulating levels of angiopoietins, which are growth factors promoting angiogenesis, were observed in patients with obesity, metabolic syndrome, and type 2 DM. However, independent of type 2 DM and obesity, defective regulation of fetuin-A and angiopoietin are playing a critical role in predisposing to coronary and peripheral vascular diseases. Therefore, mechanisms linking type 2 DM and obesity with fetuin-A and angiopoietins seem to be complex and are in need of further exploration. In this review, we aimed to present a summary concerning associations of type 2 diabetes, obesity, and vascular diseases with circulating levels of angiopoietins and fetuin-A. Furthermore, we aimed to focus on roles of fetuin-A and angiopoietins and to highlight the most plausible mechanisms that might explain their associations with type 2 DM and obesity.
ACCESSION #
83709693

 

Related Articles

  • State of the union between metabolism and the immune system in type 2 diabetes. Nikolajczyk, B S; Jagannathan-Bogdan, M; Shin, H; Gyurko, R // Genes & Immunity;Jun2011, Vol. 12 Issue 4, p239 

    Lymphocytes and myeloid cells (monocyte/macrophages) have important roles in multiple types of diseases characterized by unresolved inflammation. The relatively recent appreciation of obesity, insulin resistance and type 2 diabetes (T2D) as chronic inflammatory diseases has stimulated interest...

  • Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. GALIC, Sandra; SACHITHANANDAN, Nirupa; KAY, Thomas W.; STEINBERG, Gregory R. // Biochemical Journal;7/15/2014, Vol. 461 Issue 2, p177 

    Overactivation of immune pathways in obesity is an important cause of insulin resistance and thus new approaches aimed to limit inflammation or its consequences may be effective for treating Type 2 diabetes. The SOCS (suppressors of cytokine signalling) are a family of proteins that play an...

  • Phenylmethimazole Antagonism of Toll-like Receptor 4 (TLR4) Signaling in 3T3L-1 Adipocytes. Kelly, McCall; Dawn, Holliday; Leonard, Kohn D.; Brian, Wallace; Schwartz, Frank L. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA509 

    Acquisition of visceral obesity is recognized as important mediator of insulin resistance and the development of type 2 diabetes mellitus. It is now appreciated that inflammatory pathways are activated by visceral fat and that specific cytokines such as IL-6 and TNF-α induce insulin (IR) &...

  • Interleukin-10 Prevents Diet-Induced Insulin Resistance by Attenuating Macrophage and Cytokine Response in Skeletal Muscle. Eun-Gyoung Hong; Hwi Jin Ko; You-Ree Cho; Hyo-Jeong Kim; Zhexi Ma; Yu, Tim Y.; Friedline, Randall H.; Kurt-Jones, Evelyn; Finberg, Robert; Fischer, Matthew A.; Granger, Erica L.; Norbury, Christopher C.; Hauschka, Stephen D.; Philbrick, William M.; Chun-Geun Lee; Elias, Jack A.; Kim, Jason K. // Diabetes;Nov2009, Vol. 58 Issue 11, p2525 

    OBJECTIVE--Insulin resistance is a major characteristic of type 2 diabetes and is causally associated with obesity. Inflammation plays an important role in obesity-associated insulin resistance, but the underlying mechanism remains unclear. Interleukin (IL)-10 is an anti-inflammatory cytokine...

  • The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders. Benetti, Elisa; Chiazza, Fausto; Patel, Nimesh S. A.; Collino, Massimo // Mediators of Inflammation;2013, Vol. 2013, p1 

    The combination of obesity and type 2 diabetes is a serious health problem, which is projected to afflict 300 million people worldwide by 2020. Both clinical and translational laboratory studies have demonstrated that chronic inflammation is associated with obesity and obesity-related conditions...

  • Inflammatory Mechanisms in the Regulation of Insulin Resistance. Tilg, Herbert; Moschen, Alexander R. // Molecular Medicine;Mar/Apr2008, Vol. 14 Issue 3/4, p222 

    Insulin resistance (IR) plays a key role in the pathophysiology of obesity-related diseases such as type 2 diabetes and nonalcoholic fatty liver disease. It has been demonstrated that IR is associated with a state of chronic low-grade inflammation, and several mediators released from various...

  • Smoking in Relation to Obesity, Inflammation, Insulin Resistance and Adipokines in Men with Type 2 Diabetes. Abdella, Nabila; Mojiminiyi, Olusegun; Arouj, Monera Al; Nakhi, Abdullah Ben; Mohammedi, Hisham Al // Diabetes;Jun2007 Supplement 1, Vol. 56, pA592 

    Obesity and smoking induce several cytokines and inflammatory markers that might contribute to insulin resistance (IR) and metabolic abnormalities that increase the coronary heart disease (CHD) risk in Type 2 Diabetes (T2DM). Studies have tried to show a relationship between smoking, low-grade...

  • Follistatin-Like 1: A Potential Mediator of Inflammation in Obesity. Nengguang Fan; Haiyan Sun; Yufan Wang; Yifei Wang; Lijuan Zhang; Zhenhua Xia; Liang Peng; Yanqiang Hou; Weiqin Shen; Rui Liu; Jiajing Yin; Yongde Peng // Mediators of Inflammation;2013, Vol. 2013, p1 

    Obesity is associated with a state of chronic low-grade inflammation, which contributes to insulin resistance and type 2 diabetes. However, the molecular mechanisms that link obesity to inflammation are not fully understood. Follistatin-like 1 (FSTL1) is a novel proinflammatory cytokine that is...

  • Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes. Stefan, Norbert; Fritsche, Andreas; Weikert, Cornelia; Boeing, Heiner; Joost, Hans-Georg; Håring, Hans-Ulrich; Schulze, Matthias B. // Diabetes;Oct2008, Vol. 57 Issue 10, p2762 

    OBJECTIVE--The liver-secreted protein fetuin-A induces insulin resistance in animals, and circulating fetuin-A is elevated in insulin resistance and fatty liver in humans. We investigated whether plasma fetuin-A levels predict the incidence of type 2 diabetes in a large prospective,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics